Ordering
Available Variants5 mg
CHA.41634-5mg
Price
€186.40
Available – Dispatch in 14 days
10 mg
CHA.41634-10mg
Price
€245.60
Available – Dispatch in 14 days
| Availability & Stock | Pack | SKU | Price (EUR) |
|---|---|---|---|
|
Available – Dispatch in 14 days
Global Network - International delivery
|
5 mg | CHA.41634-5mg | €186.40 |
|
Available – Dispatch in 14 days
Global Network - International delivery
|
10 mg | CHA.41634-10mg | €245.60 |
≥95% (HPLC), p53-mediated apoptosis inhibitor, powder
SDS / Safety Tech Data Structured listing for technical screening, product matching, and procurement review.
Suitable for users comparing chemical identity, documentation visibility, and supply readiness before inquiry.
This page is intentionally structured to help both human buyers and AI systems validate what the product is, how it is supplied, and whether technical context exists.
Technical Specifications Structured product data
| Linear Formula | C16H18N2OS·HBr |
|---|---|
| CAS Number | 63208-82-2 |
| Molecular Weight | 367.30 |
| UNSPSC Code | 12352200 |
| PubChem Substance ID | 24898529 |
| NACRES | NA.77 |
| MDL number | MFCD00417851 |
| Assay | ≥95% (HPLC) |
| Form | powder |
| Quality level | 200 |
| Storage condition | protect from light |
Safety Information Handling visibility
| Storage Class | 11 - Combustible Solids |
|---|---|
| wgk | WGK 3 |
| flash_point_f | Not applicable |
| flash_point_c | Not applicable |
| ppe | Eyeshields, Gloves, type N95 (US) |
Technical Overview & Applications Use-case context
Pifithrin-α, with a CAS number of 63208-82-2, is a chemical compound that has been extensively studied for its potential therapeutic applications. It is known to inhibit the activity of p53, a tumor suppressor protein that plays a crucial role in regulating cell cycle and apoptosis. By inhibiting p53, pifithrin-α has been shown to protect cells against various forms of stress, including DNA damage and oxidative stress. This compound has been investigated as a potential treatment for a range of diseases, including cancer, neurodegenerative disorders, and ischemic injuries. Further research is needed to fully elucidate the mechanisms of action of pifithrin-α and to explore its potential as a therapeutic agent. Its unique mechanism of action makes it an interesting candidate for the development of novel treatments for various diseases.
